Investigates the Role of PANoptosis in Idiopathic Pulmonary Fibrosis and Potential Therapeutic Targets by Xiang Y, Huang G, Luo C, Jiang J, Zhang T, Zeng Q, Zhou F, Du D

Subjects: Get full text

Comparative evaluation of the impact of candesartan and ramipril therapy on the levels of GDF 15 and NTproBNP, structural and functional performance of the heart in patients with c... by V. D. Syvolap, Ya. V. Zemlyaniy

Subjects: Get full text

Candesartan effectiveness in essential arterial hypertension and renal arterial hypertension by N. M. Chikhladze, O. A. Sivakova, E. V. Blinova, T. A. Sakhnova, I. P. Kolos, G. N. Litonova, I. E. Chazova

Subjects: Get full text

Optimization and validation of UPLC method for dapagliflozin and candesartan cilexetil in an on-demand formulation: Analytical quality by design approach by Elzayat Ehab M., Kasem Hanaa M., Sherif Abdelrahman Y., Altamimi Mohammad A.

Subjects: Get full text

POSSIBILITY OF ANGIOTENSIN RECEPTOR BLOCKERS IN OPTIMIZING OF ANTIHYPERTENSIVE PHARMACOTHERAPY IN PATIENTS AFTER STROK by Z M. Sizova

Subjects: Get full text

Arterial hypertension, cardiovascular remodeling and plasma level of osteopontin in patients with end-stage kidney disease on hemodialysis by V. A. Vizir, O. G. Ovska, A. S. Sadomov

Subjects: Get full text

Candesartan cilexetil in cardiovascular prevention by A. Ya. Ivleva

Subjects: Get full text

Candesartan: A pharmaceutical product as effective corrosion inhibitor for aluminum in acidic solution by Abdel Aziz Fouda, Asmaa A. Idress, Mohamed F. Atia, Mohamed E. Yassen

Subjects: Get full text

Simultaneous Determination of Candesartan and Hydrochlorothiazide in Human Plasma by HPLC-MS/MS by P. K. Karnakova, T. N. Komarov, O. A. Archakova, D. S. Shchelgacheva, A. A. Aleshina, N. S. Bagaeva, P. A. Karpova, I. E. Shohin

Subjects: “…candesartan, hydrochlorothiazide, plasma, blood, hplc-ms/ms, validation, pharmacokinetics…”
Get full text

Identification of angiotensin II-responsive circadian clock gene expression in adrenal zona glomerulosa cells and human adrenocortical H295R cells by Tomohiro Otani, Takahito Miyake, Takumi Ota, Daisuke Yarimizu, Yuuki Nakagawa, Iori Murai, Hitoshi Okamura, Hitoshi Okamura, Emi Hasegawa, Masao Doi

Subjects: Get full text

Dynamics of structural and functional changes of the heart and the levels of GDF 15 and NTproBNP on the candesartan and ramipril therapy in patients with heart failure with preserv... by Ya. V. Zemlyaniy

Subjects: Get full text

Exploring Candesartan, an angiotensin II receptor antagonist, as a novel inhibitor of NLRP3 inflammasome: alleviating inflammation in Neisseria gonorrhoeae infection by Wen-Yu Lin, Jin-Lian Tsui, Hsiao-Wen Chiu, Wei-Ting Wong, Chun‑Hsien Wu, Hsien-Ta Hsu, Chen-Lung Ho, Shan-Pei Yeh, Yerra Koteswara Rao, Ann Chen, Chien-Chun Wang, Chung-Hua Hsu, Oleg V. Chernikov, Kuo-Feng Hua, Lan-Hui Li

Subjects: Get full text

CORRECTION OF ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH CHRONIC COR PULMONALE BY ANGIOTENSIN II RECEPTORS ANTAGONISTS by V. S. Zadionchenko, N. B. Holodkova, O. I. Nesterenko, I. V. Pogonchenkova, A. M. Shchikota, Y. V. Ignatova, I. Y. Malyshev, E. B. Manukhina, S. V. Kruglov, D. A. Pokidyshev, O. A. Zemnina

Subjects: Get full text

Comparative effects of candesartan and losartan on mesangial expansion and glomerular volume in diabetes rat model receiving rosmarinic acid therapy by Nur Samsu, Pandu Tridana Sakti, Achmad Rifai

Subjects: Get full text

Technological approaches to improve the bioavailability of the poor soluble substance Candesartan Cilexetil in mini-tablets by K. M. Tserkovnaya, E. S. Surbeeva, K. A. Gusev, E. V. Vishnyakov, E. V. Flisyuk, I. A. Narkevich

Subjects: “…candesartan cilexetil…”
Get full text

Description of cardiovascular remodeling parameters and osteopontin plasma level in dynamics of the candesartan therapy in patients with chronic kidney disease on the stage before... by V. A. Vizir, O. G. Ovska, A. S. Sadomov

Subjects: Get full text

Identification of potential SARS-CoV-2 inhibitors among well-tolerated drugs using drug repurposing and in vitro approaches by Betül Oruçoğlu, İdil Çetin, Handan Şimşek, Mehmet Topçul, Mahmut Çalışkan, Cihan Aydın, İ. Halil Kavaklı, Alper Okyar, Şeref Gül

Subjects: Get full text

From In Vivo Predictive Dissolution to Virtual Bioequivalence: A GastroPlus^®-Driven Framework for Generic Candesartan Cilexetil Tablets by Hao Ruan, Xiaoting Geng, Zijing Situ, Qian Shen, Tianjian Ye, Xin Chen, Weike Su

Subjects: “…candesartan cilexetil…”
Get full text

DYNAMICS OF PARAMETERS OF PROINFLAMMATORY ACTIVATION IN PATIENTS WITH HYPERTENSION UNDER INFLUENCE OF CANDESARTAN THERAPY by V. A. Vizir, A. S. Sadomov, O. V. Goncharov

Subjects: Get full text

Use of angiotensin receptor blockers in cardiovascular protection. Current evidence and future directions by M. A. Munger

Subjects: Get full text